Showing results (1191-1200 of 1,252) with videos related to
Sort By:
Pageof 126
Journal of Medicinal Chemistry|March 19, 2004
Design and synthesis of a fluoroindolocarbazole series as selective topoisomerase I active agents. Discovery of water-soluble 3,9-difluoro-12,13-dihydro-13-[6-amino-beta-D-glucopyranosyl]-5H,13H-benzo[b]- thienyl[2,3-a]pyrrolo[3,4-c]carbazole- 5,7(6H)-dione (BMS-251873) with curative antitumor activity against prostate carcinoma xenograft tumor modelBalu N Balasubramanian, Denis R St Laurent, Mark G Saulnier, et al.Autism Research : Official Journal of the International Society for Autism Research|July 16, 2016
Non-ASD outcomes at 36 months in siblings at familial risk for autism spectrum disorder (ASD): A baby siblings research consortium (BSRC) studyTony Charman, Gregory S Young, Jessica Brian, et al.The Journal of Molecular Diagnostics : JMD|November 5, 2013
A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platformsMichèle Beau-Faller, Hélène Blons, Caroline Domerg, et al.Nature Medicine|April 24, 2019
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetesMonika A Niewczas, Meda E Pavkov, Jan Skupien, et al.Science Translational Medicine|August 10, 2022
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetesHiroki Kobayashi, Helen C Looker, Eiichiro Satake, et al.Cancer Discovery|January 17, 2023
Targeting Microglial Metabolic Rewiring Synergizes with Immune-Checkpoint Blockade Therapy for GlioblastomaZengpanpan Ye, Xiaolin Ai, Kailin Yang, et al.Nature Methods|June 23, 2014
All-optical electrophysiology in mammalian neurons using engineered microbial rhodopsinsDaniel R Hochbaum, Yongxin Zhao, Samouil L Farhi, et al.Journal of Medicinal Chemistry|April 2, 2005
Discovery of a fluoroindolo[2,3-a]carbazole clinical candidate with broad spectrum antitumor activity in preclinical tumor models superior to the marketed oncology drug, CPT-11Mark G Saulnier, Balu N Balasubramanian, Byron H Long, et al.Molecular Cell|May 13, 2022
Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regionsJulien Vibert, Olivier Saulnier, Céline Collin, et al.International Journal of Cancer|July 29, 2011
Inactivation of the putative suppressor gene DOK1 by promoter hypermethylation in primary human cancersAmandine Saulnier, Thomas Vaissière, Jiping Yue, et al.Pageof 126